Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvoxamine for Melancholia
NCT04160377Phase 2Unknown
- Start
- Aug 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluvoxamine in major depressive disorder (MDD). Status: unknown.
02
Drugs
fluvoxamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04160377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04160377.